EXPERIMENTAL DRUG-TREATMENT OF SCRAPIE - A PATHOGENETIC BASIS FOR RATIONALE THERAPEUTICS

被引:11
作者
POCCHIARI, M
SALVATORE, M
LADOGANA, A
INGROSSO, L
XI, YG
CIBATI, M
MASULLO, C
机构
[1] Department of Biology, University of Lecce, Lecce
[2] Institute of General Pathology, Catholic University, Rome
[3] Institute of Neurology, Catholic University, Rome
关键词
SCRAPIE; CREUTZFELDT-JAKOB DISEASE; THERAPY; AMPHOTERICIN-B; SULFATE POLYANIONS; PATHOGENESIS;
D O I
10.1007/BF00143139
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Pharmacological treatment with polyanions or amphotericin B in hamsters with experimental scrapie reveals that it is possible to delay the appearance of the disease only when the drug is given before the invasion of the agent into the clinical target areas of the brain. We suggest such early treatment may be possible for individuals at high risk of acquiring the disease, such as healthy mutation-positive relatives of patients with familial Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome, or recipients of potentially contaminated pituitary-extracted human growth hormone.
引用
收藏
页码:556 / 561
页数:6
相关论文
共 36 条
[1]  
Billette de Villemeur T., Beauvais P., Gourmelen M., Richardet J.M., Creutzfeldt-Jakob disease in children treated with growth hormone, Lancet, 337, pp. 864-865, (1991)
[2]  
Brown P., A therapeutic panorama of the spongiform encephalopathies, Antiviral Chemistry and Chemotherapy, 1, pp. 75-83, (1990)
[3]  
Brown P., Transmissible spongiform encephalopathies in humans: kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease, Can. J. Vet. Res., 54, pp. 38-41, (1990)
[4]  
Brown P., Gajdusek D.C., Gibbs C.J., Asher D.M., Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy, N. Engl. J. Med., 313, pp. 728-731, (1985)
[5]  
Brown P., Goldfarb L.G., Gajdusek D.C., The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist, Lancet, 337, pp. 1019-1022, (1991)
[6]  
Buchanan C.R., Preece M.A., Milner R.D.G., Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom, Br. Med. J., 302, pp. 824-828, (1991)
[7]  
Bruce M., Dickinson A.G., Biological evidence that scrapie agent has an independent genoma, J. Gen. Virol., 68, pp. 79-89, (1987)
[8]  
Casaccia P., Ladogana A., Xi Y.G., Pocchiari M., Levels of infectivity in the blood through the incubation period of hamsters peripherally injected with scrapie, Arch. Virol., 108, pp. 145-149, (1989)
[9]  
Dickinson A.G., Scrapie in sheep and goats, Slow Virus Diseases of Animal and Man, pp. 209-241, (1976)
[10]  
Dickinson A.G., Fraser H., Scrapie: effect of Dh gene on incubation period of extraneurally injected agent, Heredity, 29, pp. 91-93, (1972)